Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on October 25, 2017, to report its financial results for the third quarter ended September 30, 2017. This filing primarily serves to furnish a press release detailing these results, which is incorporated by reference as Exhibit 99.1. While the 8-K itself does not contain the specific financial figures, it directs investors to the furnished press release for detailed information on the company's performance during the quarter. Investors should review Exhibit 99.1 to understand the company's revenue, earnings, and other key financial metrics for the period, as well as any forward-looking guidance or commentary provided by management.
Key Highlights
- 1Elevance Health (Anthem, Inc.) announced its third-quarter 2017 financial results via an 8-K filing.
- 2The core of the filing is the furnishing of a press release (Exhibit 99.1) containing the detailed financial results.
- 3The press release covers the third quarter ended September 30, 2017.
- 4This 8-K filing does not contain the actual financial results within the report itself; investors must refer to the attached press release.
- 5Information furnished under Item 2.02 and Exhibit 99.1 is not considered 'filed' for Section 18 purposes.
- 6This filing is primarily an informational disclosure of previously released financial results.
Frequently Asked Questions
The specific financial results for the third quarter ended September 30, 2017, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. You will need to access that exhibit for the complete financial details.
No, this 8-K filing does not contain detailed financial statements within the report itself. It only indicates that a press release with the company's financial results has been issued and is provided as an exhibit.
Information furnished under Item 2.02 and incorporated exhibits are typically not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means that liability under Section 18 for making false or misleading statements does not apply to this furnished information, although it is still available for investors to review.
The press release reporting the third-quarter financial results was dated October 25, 2017, and the 8-K filing was also made on October 25, 2017, with the event date being October 24, 2017.